Destiny Pharma plc announced the departure of Chairman, Nick Rodgers, who has resigned to pursue other interests. Discussions with a new outside chairman are very advanced with a further announcement expected shortly.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.3 GBX | +3.46% | -4.15% | -76.72% |
25/04 | Norcros sells Johnson Tiles UK; Trifast trading well | AN |
25/04 | Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-76.72% | 1.89Cr | |
+5.33% | 11TCr | |
+12.11% | 11TCr | |
-12.56% | 2.22TCr | |
-3.67% | 2.13TCr | |
-5.99% | 1.9TCr | |
-35.21% | 1.85TCr | |
-10.86% | 1.68TCr | |
+37.57% | 1.25TCr | |
-26.24% | 808.97Cr |
- Stock Market
- Equities
- DEST Stock
- News Destiny Pharma plc
- Destiny Pharma plc Announces Departure of Nick Rodgers as Chairman